Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders

Regenerative Medicine

Volumn 5, Issue 3, 2010, Pages 381-394

  Sandrock, Robert W ^a,b   Wheatley, Will ^a   Levinthal, Cynthia ^a   Lawson, Jennifer ^a   Hashimoto, Brooke ^a   Rao, Mahendra ^c   Campanelli, James T ^a  

^a Q Therapeutics Inc   (United States)

^b ARUP LABORATORIES   (United States)

^c Life Technologies   (United States)

Author keywords

Amyotrophic lateral sclerosis; Glial restricted progenitor cell; Good manufacturing practice; Regenerative medicine; Stem cell therapy; Transverse myelitis

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CELL SEPARATION; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; FEMALE; FREEZE THAWING; GESTATIONAL AGE; GLIAL RESTRICTED PROGENITOR CELL; GOOD MANUFACTURING PRACTICE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; ANIMAL; CELL TRANSPLANTATION; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; FOREBRAIN; GLIA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NEURODEGENERATIVE DISEASES; PROCEDURES; REGENERATIVE MEDICINE; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSPLANTATION; EPITOPES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEURODEGENERATIVE DISEASES; NEUROGLIA; PROSENCEPHALON; REGENERATIVE MEDICINE; STEM CELLS;

EID: 77952273950     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.24     Document Type: Article

References (26)

1. Windrem MS, Nunes MC, Rashbaum WK et al.: Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat. Med. 10(1), 93-97 (2004).
2. Benarroch EE: Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 80(10), 1326-1338 (2005).
3. Windrem MS, Schanz SJ, Guo M et al.: Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2(6), 553-565 (2008).
4. Cao Q, Xu XM, Devries WH et al.: Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J. Neurosci. 25(30), 6947-6957 (2005).
5. Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ: Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol. 5(3), 7 (2006).
6. Lepore AC, Rauck B, Dejea C et al.: Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11(11), 1294-1301 (2008).
7. Mitsui T, Shumsky JS, Lepore AC, Murray M, Fischer I: Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 25(42), 9624-9636 (2005).
8. Dubois C, Manuguerra JC, Hauttecoeur B, Maze J: Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative. J. Biol. Chem. 265(5), 2797-2803 (1990).
9. Nakamura K, Kojima H, Suzuki M, Suzuki A, Tamai Y: Novel polysialogangliosides of skate brain structural determination of tetra, penta and hexasialogangliosides with a NeuAc-GalNAc linkage. Eur. J. Biochem. 267(16), 5198-5208 (2000).
10. Saito M, Kitamura H, Sugiyama K: The specificity of monoclonal antibody A2B5 to c-series gangliosides. J. Neurochem. 78(1), 64-74 (2001).
11. Dietrich J, Noble M, Mayer-Proschel M: Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 40(1), 65-77 (2002).
12. Rao MS, Mayer-Proschel M: Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev. Biol. 188(1), 48-63 (1997). (Pubitemid 27360086)
13. Eisenbarth GS, Walsh FS, Nirenberg M: Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl Acad. Sci. USA 76(10), 4913-4917 (1979).
14. Eisenbarth GS, Shimizu K, Bowring MA, Wells S: Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. Proc. Natl Acad. Sci. USA 79(16), 5066-5070 (1982).
15. Merzak A, Koochekpour S, Pilkington GJ: Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro. Neurosci. Lett. 177(1-2), 44-46 (1994).
16. Raff MC, Abney ER, Cohen J, Lindsay R, Noble M: Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J. Neurosci. 3(6), 1289-1300 (1983).
17. Schnitzer J, Schachner M: Cell type specificity of a neural cell surface antigen recognized by the monoclonal antibody A2B5. Cell Tissue Res. 224(3), 625-636 (1982).
18. Yamamura K, Mishima Y: Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis: anti-ganglioside and anti-ras p21 antibodies as markers of tumor progression. J. Invest. Dermatol. 94(2), 174-182 (1990).
19. Satoh J, Kim SU: Ganglioside markers GD3, GD2, and A2B5 in fetal human neurons and glial cells in culture. Dev. Neurosci. 17(3), 137-148 (1995).
20. Noble M, Proschel C, Mayer-Proschel M: Getting a GR(i)P on oligodendrocyte development. Dev. Biol. 265(1), 33-52 (2004).
21. Rao MS, Noble M, Mayer-Proschel M: A tripotential glial precursor cell is present in the developing spinal cord. Proc. Natl Acad. Sci. USA 95(7), 3996-4001 (1998).
22. Strathmann FG, Wang X, Mayer-Proschel M: Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins. BMC Dev. Biol. 7, 33 (2007).
23. Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303(5916), 390-396 (1983).
24. Nave KA: Neurological mouse mutants and the genes of myelin. J. Neurosci. Res. 38(6), 607-612 (1994).
25. Privat A, Jacque C, Bourre JM, Dupouey P, Baumann N: Absence of the major dense line in myelin of the mutant mouse "shiverer". Neurosci. Lett. 12(1), 107-112 (1979). (Pubitemid 9194932)
26. Shinkai Y, Rathbun G, Lam KP et al.: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68(5), 855-867 (1992).